Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Active control----1件: 13 💬
2Best medical treatment FOR management OF impulse control IN parkinson´S disease according TO widely accepted expert consensus paper----1件: 6 💬
3Blood analysis FOR hypercalcemia'S control----1件: 18 💬
4Blood drawing IN healthy controls----1件: 65 💬
5Boots high strength garlic odour controlled----1件: 299 💬
6Carbidopa and levodopa controlled release tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
7Coenzyme Q-10 IN normal control subjects1件: Ubidecarenone1件: Ubidecarenone 💬 --1件: 86 💬
8Control diet----2件: 96, 97 💬
9Control GEL----1件: 36 💬
10Control group 0.9% isotonic saline----1件: 299 💬
11Control group typically developing----1件: 113 💬
12Control group: mesalazine enema treatment----1件: 97 💬
13Control multivitamin----1件: 299 💬
14Control surgery----1件: 6 💬
15Control wound treatment----1件: 36 💬
16Controlled-release levodopa / carbidopa----1件: 6 💬
17Cornstarch control1件: Starch, corn1件: Corn starch 💬 --1件: 90 💬
18Diazoxide choline controlled-release tablet1件: Diazoxide2件: Diazoxide ,
Diazoxide choline 💬 		2件: ABCC8,
KCNJ11 💬 		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 193 💬
19Evaluation OF lower extremity muscle strength, physical activity, exercise capacity, balance, quality OF life, and fatigue IN healthy controls----1件: 13 💬
20Group 1- control diet----1件: 97 💬
21Healthy AGE-matched controls----1件: 6 💬
22Healthy controls----1件: 63 💬
23High dose vehicle control----1件: 46 💬
24Histamine
(POSITIVE SKIN TEST CONTROL - HISTAMINE)		1件: Histamine3件: Histamine dihydrochloride (POSITIVE SKIN TEST CONTROL - HISTAMINE),
Histamine phosphate ,
Histamine 💬 		4件: HRH1,
HRH2,
HRH3,
HRH4 💬 		5件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 13 💬
25Historical control----1件: 2 💬
26IN vitro stimulation OF blood with periodontitis-associated- and control bacteria----1件: 46 💬
27Infliximab control1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
28LOW blood pressure control----1件: 67 💬
29LOW dose vehicle control----1件: 46 💬
30LOW-FAT control diet----1件: 124 💬
31Normal (control) diet----1件: 240 💬
32Observational control----1件: 13 💬
33Protein and calorie controlled diet----1件: 251 💬
34Reaction time and postural control----1件: 299 💬
35Ropinirole controlled-release (requip CR) FOR RLS1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
36Sham control----1件: 3 💬
37Standard blood pressure control----1件: 67 💬
38Treatment VS control bread----1件: 97 💬
39Vehice control----1件: 96 💬
40Vehicle control----2件: 36, 53 💬